Pages that link to "Q35181018"
Jump to navigation
Jump to search
The following pages link to Thalidomide derived immunomodulatory drugs (IMiDs) as potential therapeutic agents (Q35181018):
Displaying 7 items.
- Cytokine modulators in the treatment of sarcoidosis (Q34190083) (← links)
- Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transpla (Q35999062) (← links)
- Immunomodulating drugs for chronic lymphocytic leukaemia (Q36496055) (← links)
- Novel approaches for the treatment of NHL: Proteasome inhibition and immune modulation (Q37280938) (← links)
- A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma. (Q38364912) (← links)
- Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma (Q38551337) (← links)
- Maintenance therapy following induction chemoimmunotherapy in patients with diffuse large B-cell lymphoma: current perspective (Q50089372) (← links)